Related Experiment Video
Updated: May 15, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Mite hypersensitivity in patients with rhinitis and rhinosinusitis living in a tropical environment
M Sánchez-Borges1, E Fernández-Caldas2, A Capriles-Hulett3
1Allergy and Clinical Immunology Department, Centro Médico-Docente La Trinidad, Caracas, Venezuela; Clínica El Avila, Caracas, Venezuela.
Purpose:
Rhinitis and rhinosinusitis are major concerns in public health. Mites are important aetiological agents in the tropics. The present study investigated the in vivo response to mite allergens in patients with rhinitis and rhinosinusitis.
Methods:
All patients with presumptive nasal allergy were included. Skin tests were done with inhalants and mite extracts. Patients were classified as allergic or non-allergic according to skin tests and history.
Results:
Out of 229 patients, 175 (76.4%) showed positive skin tests. Allergic patients showed positivity to mites in 97.1% of cases, 51.4% to dog dander; 40.5% to cat dander; 36.5% to German cockroach; 22.8% to moulds; and 21.1% to grass pollens. Dermatophagoides farinae induced responses in 90.8% of patients, D. pteronyssinus in 90.1%, Blomia tropicalis in 74.8%, Glycyphagus domesticus in 62.2%, Chortoglyphus arcuatus in 58.2%, Acarus siro in 46.2%, Lepidoglyphus destructor in 35.4%, and Tyrophagus putrescentiae in 35.0%. Higher correlations were found between skin test diameters induced by mites from the same family.
Conclusions:
Sensitisation to inhalant allergens is present in 76% of allergy clinics' patients with rhinitis or rhinosinusitis. Our results confirm previous observations showing that mites constitute the most important cause of respiratory allergy in tropical settings and suggest that mite allergen cross-reactivity is responsible for the positivity of skin tests to mites not present in the patient's environment since the species Glycyphagus, Chortoglyphus, Acarus, Lepidoglyphus and Tyrophagus have not been found in Caracas house dust.
Insights
Mites are a primary cause of respiratory allergies in tropical regions, affecting over 76% of patients with rhinitis and rhinosinusitis. This study highlights the significant role of mite allergens in allergic reactions, even those not typically found in a patient's environment.
Area of Science:
- Allergy and Immunology
- Environmental Health
- Tropical Medicine
Background:
- Rhinitis and rhinosinusitis are significant public health issues, particularly in tropical regions where mites are prevalent etiological agents.
- Understanding the specific allergens triggering these conditions is crucial for effective management and public health strategies.
Purpose of the Study:
- To investigate the in vivo immune response to various mite allergens in patients diagnosed with rhinitis and rhinosinusitis.
- To determine the prevalence of sensitization to different inhalant allergens, with a focus on mites, in patients attending allergy clinics.
Main Methods:
- Inclusion of all patients presenting with presumptive nasal allergy symptoms.
- Performance of skin prick tests using a range of inhalant allergens, including specific mite extracts.
- Classification of patients into allergic or non-allergic groups based on skin test results and clinical history.
Main Results:
- Out of 229 patients, 76.4% exhibited positive skin test reactions to inhalant allergens.
- Allergic patients demonstrated high sensitization rates to mites, with Dermatophagoides species (D. farinae and D. pteronyssinus) showing over 90% positivity.
- Significant cross-reactivity was observed among mite allergens from the same taxonomic family, suggesting shared allergenic epitopes.
Conclusions:
- Mites are confirmed as the predominant cause of respiratory allergies in tropical environments, impacting a substantial majority of patients with rhinitis or rhinosinusitis.
- The findings suggest that cross-reactivity to mite allergens, even those not endemic to the local environment, plays a critical role in positive skin test results and allergic responses.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in various...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
